Tumor necrosis factor and tuberculosis

被引:119
|
作者
Lin, Philana Ling [1 ]
Plessner, Hillarie L.
Voitenok, Nikolai N.
Flynn, JoAnne L.
机构
[1] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Mol Genet & Biochem, Sch Med, Pittsburgh, PA 15261 USA
[3] Fund Mol Hematol & Immunol, Moscow, Russia
关键词
D O I
10.1038/sj.jidsymp.5650027
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tumor necrosis factor (TNF) plays a major role in the initial and long-term control of tuberculosis. The mechanisms by which this cytokine contributes to the control of Mycobacterium tuberculosis infection are numerous and therefore difficult to dissect. TNF is important in macrophage activation as well as cell recruitment to the site of infection. It is the primary signal important in granuloma formation, as neutralization of this cytokine leads to lack of control of initial or chronic infection, and loss of granuloma structure. In humans treated with TNF-neutralizing drugs, an increased susceptibility to tuberculosis, as well as other infectious diseases, is observed. We are using animal models to understand how TNF neutralization by these drugs can lead to reactivation of tuberculosis.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 50 条
  • [1] ALCOHOL, TUMOR-NECROSIS-FACTOR, AND TUBERCULOSIS
    NELSON, S
    MASON, C
    BAGBY, G
    SUMMER, W
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1995, 19 (01) : 17 - 24
  • [2] Trouble With Tumor Necrosis Factor α Inhibitors, Not Just Tuberculosis
    Racunica, Tina
    Cassidy, Dermot
    Cicuttini, Flavia M.
    Hall, Anthony
    ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 770 - 774
  • [3] Tuberculosis Infections and Tumor Necrosis Factor Alpha Antagonists
    Gan, Justin
    Manadan, Augustine M.
    Sequiera, Winston
    Block, Joel A.
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (01) : 73 - 78
  • [4] Review: Reactivation of tuberculosis by tumor necrosis factor neutralization
    Jacobs, Muazzam
    Samarina, Arina
    Grivennikov, Sergei
    Botha, Tania
    Allie, Nasiema
    Fremond, Cecile
    Togbe, Dieudonne
    Vasseur, Virginie
    Rose, Stephanie
    Erard, Francois
    Monteir, Analbery
    Quesniaux, Valerie
    Ryffel, Bernhard
    EUROPEAN CYTOKINE NETWORK, 2007, 18 (01) : 5 - 13
  • [5] Tumor necrosis factor is critical to control tuberculosis infection
    Jacobs, Muazzam
    Togbe, Dieudonnee
    Fremond, Cecile
    Samarina, Arina
    Allie, Nasiema
    Botha, Tania
    Carlos, Daniela
    Parida, Shreemanta K.
    Grivennikov, Sergei
    Nedospasov, Sergei
    Monteiro, Analbery
    Le Bert, Marc
    Quesniaux, Valerie
    Ryffel, Bemhard
    MICROBES AND INFECTION, 2007, 9 (05) : 623 - 628
  • [6] Tumor Necrosis Factor-α Blocker Induced Tuberculosis
    Kharbanda, Priyanka
    Dagaonkar, Rucha
    Balakrishnan, Canchi
    Udwadia, Zarir F.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1542 - 1543
  • [7] Tumor necrosis factor blockers and reactivation of latent tuberculosis
    Keane, J
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) : 300 - 302
  • [8] Tuberculosis associated with therapy against tumor necrosis factor α
    Winthrop, KL
    Siegel, JN
    Jereb, J
    Taylor, Z
    Iademarco, MF
    ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 2968 - 2974
  • [9] Tuberculosis and tumor necrosis factor alpha antagonist: Our experience
    Reina Marfil, Nuria Maria
    Ortega Saenz de Tejada, Ezequiel
    Lopez Lopez, Lidia
    Franco Torres, Ana Milena
    Velasco Garrido, Jose Luis
    Fernandez Aguirre, Carmen
    Hidalgo Sanjuan, Maria Victoria
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [10] Anti tumor necrosis factor α (TNF-α) and risks of tuberculosis
    de Paula, Diogo F.
    ACTA REUMATOLOGICA PORTUGUESA, 2014, 39 (02): : 195 - 196